Literature DB >> 26855317

Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.

Akvilė Jarmalavičiūtė1, Augustas Pivoriūnas2.   

Abstract

Exosomes are extracellular vesicles that can transfer biological information over long distances affecting normal and pathological processes throughout organism. It is known that very often composition and therapeutic properties of exosomes depends on cell type and its physiological state. Thus, depending on tissue of origin and physiological context exosomes may act as promoters, or suppressors of pathological processes in CNS. From the therapeutic perspective, the most promising cellular sources of exosomes are mesenchymal stem cells, dendritic cells and inducible pluripotent stem cells. In this review, we will summarize the current state of knowledge on the molecular mechanisms underlying neuroprotective actions of exosomes derived from these cells. New therapies for the neurodegenerative disorders are often halted by the inability of drugs to cross blood-brain barrier. In this respect exosomes have a critical advantage, because they can cross blood-brain barrier. Despite the great importance, surprisingly little is known about mechanistic details of this process. Therefore we will discuss some recent findings that may explain mechanisms of exosomal entry into the brain.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Exosomes; Neurodegeneration; Neuroprotection

Mesh:

Substances:

Year:  2016        PMID: 26855317     DOI: 10.1016/j.phrs.2016.02.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  26 in total

1.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

2.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination.

Authors:  Yunbing Wu; Wei Qiu; Xinwei Xu; Jingjing Kang; Jingyan Wang; Yingying Wen; Xudong Tang; Yongmin Yan; Hui Qian; Xu Zhang; Wenrong Xu; Fei Mao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

4.  Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys.

Authors:  Veronica Go; Bethany G E Bowley; Monica A Pessina; Zheng Gang Zhang; Michael Chopp; Seth P Finklestein; Douglas L Rosene; Maria Medalla; Benjamin Buller; Tara L Moore
Journal:  Geroscience       Date:  2019-11-06       Impact factor: 7.713

Review 5.  Human Pluripotent Stem Cell-Derived Extracellular Vesicles: Characteristics and Applications.

Authors:  Richard Jeske; Julie Bejoy; Mark Marzano; Yan Li
Journal:  Tissue Eng Part B Rev       Date:  2020-01-16       Impact factor: 6.389

Review 6.  Exosomes in Parkinson's Disease.

Authors:  Xiaoqing Wu; Tingting Zheng; Baorong Zhang
Journal:  Neurosci Bull       Date:  2016-12-26       Impact factor: 5.203

7.  Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.

Authors:  Yan Hong; Ting Zhao; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-09-11       Impact factor: 6.167

Review 8.  Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis.

Authors:  Giuliana Di Rocco; Silvia Baldari; Gabriele Toietta
Journal:  Stem Cells Int       Date:  2016-11-23       Impact factor: 5.443

Review 9.  Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.

Authors:  Miao He; Hai-Nan Zhang; Zhen-Chu Tang; Shu-Guang Gao
Journal:  Neural Plast       Date:  2021-05-16       Impact factor: 3.599

10.  Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR.

Authors:  Xavier Gallart-Palau; Aida Serra; Siu Kwan Sze
Journal:  Mol Neurodegener       Date:  2016-05-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.